These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20332341)

  • 21. Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected by culture-based diagnostic procedures and persist after treatment arrest.
    Moreillon P; Bizzini A; Giddey M; Vouillamoz J; Entenza JM
    J Antimicrob Chemother; 2012 Mar; 67(3):652-60. PubMed ID: 22167243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Searching for Staphylococcus aureus strains with reduced susceptibility to glycopeptides among clinical isolates obtained during the year of 2002].
    Młynarczyk A; Młynarczyk G; Łuczak M
    Med Dosw Mikrobiol; 2003; 55(3):209-17. PubMed ID: 14702662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
    Sader HS; Jones RN; Rossi KL; Rybak MJ
    J Antimicrob Chemother; 2009 Nov; 64(5):1024-8. PubMed ID: 19744978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC
    Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia model.
    Hegde SS; Difuntorum S; Skinner R; Trumbull J; Krause KM
    J Antimicrob Chemother; 2009 Apr; 63(4):763-6. PubMed ID: 19155225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
    Hoşgör Limoncu M; Ermertcan S; Taşli H; Kurutepe S
    Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.
    Sakoulas G; Moellering RC; Eliopoulos GM
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S40-50. PubMed ID: 16323119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals.
    Nonhoff C; Denis O; Struelens MJ
    Clin Microbiol Infect; 2005 Mar; 11(3):214-20. PubMed ID: 15715719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
    Cartolano GL; Cheron M; Benabid D; Leneveu M; Boisivon A;
    Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a tertiary care center.
    Maor Y; Rahav G; Belausov N; Ben-David D; Smollan G; Keller N
    J Clin Microbiol; 2007 May; 45(5):1511-4. PubMed ID: 17344363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and Clinical Impact of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolated From Hospitalized Patients.
    Koh YR; Kim KH; Chang CL; Yi J
    Ann Lab Med; 2016 May; 36(3):235-43. PubMed ID: 26915612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
    Maclayton DO; Hall RG
    Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection of the first strain of glycopeptide intermediary Staphylococcus aureus in Tunis Rabta hospital].
    Zribi M; Etienne J; El Euch D; Zribi H; Bes M; Meugnier H; Masmoudi A; Osman AB; Fendri C
    Pathol Biol (Paris); 2011 Dec; 59(6):334-5. PubMed ID: 19942369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Key considerations in the treatment of complicated staphylococcal infections.
    Jones RN
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-level glycopeptide resistance in methicillin-resistant Staphylococcus aureus and how to test it.
    Hawkey PM
    Clin Microbiol Infect; 2009 Dec; 15 Suppl 7():2-9. PubMed ID: 19951328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.
    Fridkin SK
    Clin Infect Dis; 2001 Jan; 32(1):108-15. PubMed ID: 11118389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamic effect of clinical vancomycin exposures on cell wall thickness in heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Rose WE; Knier RM; Hutson PR
    J Antimicrob Chemother; 2010 Oct; 65(10):2149-54. PubMed ID: 20693174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Fourier transform infrared spectroscopy for the rapid identification of glycopeptide-intermediate Staphylococcus aureus.
    Amiali NM; Mulvey MR; Berger-Bächi B; Sedman J; Simor AE; Ismail AA
    J Antimicrob Chemother; 2008 Jan; 61(1):95-102. PubMed ID: 17962217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of the Etest GRD for detecting Staphylococcus aureus with reduced susceptibility to glycopeptides in cystic fibrosis patients.
    Filleron A; Chiron R; Reverdy ME; Jean-Pierre H; Dumitrescu O; Aleyrangues L; Counil F; Jumas-Bilak E; Marchandin H
    Eur J Clin Microbiol Infect Dis; 2012 Apr; 31(4):599-604. PubMed ID: 21904858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.